Poster Abstract Session:
051. Emerging Resistance - Epidemiology and Mechanisms
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID, Pediatric ID


Presentations:
316
Characteristics of Streptococcus pneumoniae  Serotype 19A Isolates from Children in the pre and post Conjugate Vaccine Era
Emmanouil I. Koutouzis, MD; George L. Daikos, MD; Panagiota Chatzichristou, Β.Sc; Athanasios Michos, MD; Athanasios Tsakris, Prof; Foteini I. Koutouzi, MD; Vassiliki Syriopoulou, MD
Posters
  • Pneumo 19A IDWeek 2017.pdf (941.9 kB)
  • 317
    Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity
    Truc T. Tran, PharmD; Lorena Diaz, PhD; Henrietta Abodakpi, MS; Javier Ardila, MSc; Elsa De La Cadena, MSc; Rafael Rios, MSc; William Miller, MD; Lina Rivas, MSc; An Dinh, BS; Paola Porras, BSc; Diana Panesso, PhD; Vincent Tam, PharmD; Jose M. Munita, MD; Cesar Arias, MD, PhD, FIDSA
    318
    Reduced Ertapenem Susceptibility Due to OXA-2 Production in Klebsiella pneumoniae ST258
    Alina Iovleva, MD; Roberta Mettus, BS; Christi McElheny, MS; Anthony Pasculle, ScD; Yohei Doi, MD, PhD
    319
    Co-occurrence of NDM-5, OXA-181 and CMY-2 in a Clinical E. coli Isolate From a Patient in the United States
    William Miller, MD; Rafael Rios, MSc; Lorena Diaz, PhD; Diana Panesso, PhD; Michael Chang, MD; Zhizeng Sun, PhD; Timothy Palzkill, PhD; Cesar Arias, MD, PhD, FIDSA
    321
    Frequency and Mechanisms of Spontaneous Fosfomycin Non-susceptibility Observed upon Disk Diffusion Testing of Escherichia coli
    Aaron Lucas, MD; Ryota Ito, MD, PhD; Mustapha Mustapha, PhD; Christi McElheny, MS; Roberta Mettus, BS; Sarah Bowler, BS; Serena Kantz, BS; Anthony Pasculle, ScD; Vaughn Cooper, PhD; Yohei Doi, MD, PhD
    322
    The Gastrointestinal Tract is a Major Source of Echinocandin Drug Resistance in a Candida glabrata Colonization Mouse Model
    Kelley Healey, Ph.D.; Yanan Zhao, Ph.D.; Yoji Nagasaki, MD; Steven Park, M.S.; David Perlin, Ph.D.
    323
    Genomic Pathways Associated With Daptomycin (DAP) Resistance in DAP-Susceptible Enterococcus faecium Harboring Substitutions in LiaFSR
    Truc T. Tran, PharmD; Lorena Diaz, PhD; Rafael Rios, MSc; An Dinh, BS; Seyedehameneh Jahanbakhsh, PharmD; Razieh Kebriaei, PharmD; Michael J. Rybak, PharmD, MPH, PhD; Cesar Arias, MD, PhD, FIDSA
    324
    Emergence of mcr-1 among Nontyphoidal Salmonella Isolates in the United States
    Louise Francois Watkins, MD, MPH; Jason Folster, PhD; Jessica Chen, PhD; Maria S. Karlsson, PhD; Sandra Boyd, BS; Vivian Leung, MD; Alycia McNutt, BS; Carlota Medus, PhD, MPH; Xiong Wang, DVM, PhD; Samir Hanna, MD; Nailah Smith, DVM, MPH; Ana Colón, MPH; Anna Barringer, CPH; Cheryl Dunbar-Manley, BSN, RN; Juanita Balk, BSN, RN; Cindy Friedman, MD
    325
    Lack of Fosfomycin Resistance in Commensal E. coli after Fosfomycin Treatment
    Roberta Mettus, BS; Serena Kantz, BS; Sarah Bowler, BS; Christi McElheny, MS; Anthony Pasculle, ScD; Yohei Doi, MD, PhD
    326
    β-lactamase Characterization of Baseline Pseudomonas aeruginosa (PSA) from Five Ceftazidime-avibactam (CAZ-AVI) Phase 3 Clinical Trials
    Rodrigo E. Mendes, Ph.D.; Mariana Castanheira, PhD; Leah N. Woosley, B.S.; Gregory G. Stone, Ph.D.; Robert Mclaughlin, PhD; Patricia Bradford, PhD; Robert K. Flamm, PhD
    327
    The association of mRNA expression of cell wall biosynthesis related genes and the reversion to daptomycin (DAP) susceptibility in DAP non-susceptible methicillin-resistant Staphylococcus aureus 
    Yasunori Iwata, M.D., PhD; Kenji Satou, PhD; Taizo Wada, M.D., PhD; Yasuko Senda, PhD; Yukiko Takemori-Sakai, PhD; Takashi Wada, M.D., PhD
    328
    Dominance of a macrolide resistant lineage resulting from capsular switching among group B Streptococcus invasive disease in non-pregnant adults in Portugal (2009-2015
    Elísia Lopes, MSc; Tania Fernandes, MSc; Miguel P Machado, MSc; João A Carriço, PhD; Jose Melo-Cristino, MD, PhD; Mario Ramirez, PhD; Elisabete Martins, PhD
    329
    Sustained In Vitro Activity of Linezolid and Evolving Resistance Mechanisms: Summary of the Zyvox® Annual Appraisal of Potency and Spectrum Program for 2016
    Rodrigo E. Mendes, Ph.D.; Patricia A. Hogan, MBA; Mariana Castanheira, PhD; Helio S. Sader, MD, PhD; Robert K. Flamm, PhD
    Posters
  • IDWeek2017-ZAAPS.pdf (651.1 kB)
  • 330
    Emerging Carbapenem Resistant Aeromonas Infections in Cali, Colombia.
    Fernando Rosso, MD, MSc; Jolian Velez, MD; Jorge Cedano, MD; Maria Hormaza, MD; Adriana Correa, PhD; Alejandra Toala, Microbiology
    Posters
  • Aeromonas.pdf (2.0 MB)
  • 331
    Molecular Characterization of Fluoroquinolone Resistance Mechanisms in Isolates from the Delafloxacin Acute Bacterial Skin and Skin Structure Infections Clinical Trials
    Rodrigo E. Mendes, Ph.D.; Dee Shortridge, Ph.D.; Sandra P. McCurdy, M.S.; Sue K. Cammarata, MD; Michael D. Huband, BS; Robert K. Flamm, PhD
    334
    Antimicrobial Susceptibility Assessment of Clinical Clostridium difficile Isolates in Relation to CRISPR-Cas
    Irtiza Hasan, MD; Tasnuva Rashid, MD, MPH; Khurshida Begum, PhD; M. Jahangir Alam, PhD; Kevin Garey, PharmD, MS
    335
    Low Prevalence of Azole Resistance in Aspergillus fumigatus in Australia, and Molecular Characterisation of Resistant Isolates
    Shradha Subedi, FRACP, FRCPA; Catriona Halliday, PhD; Jessica Talbot, BVSc (hons); Chayanika Biswas, PhD; Louise Cooley, FRACP, FRCPA; Dee Carter, PhD; Tania Sorrell, MD; Vanessa Barrs*, PhD; Sharon Chen*, PhD
    Posters
  • Azole resistance.pdf (1.3 MB)
  • 336
    A Novel Mechanism of Resistance Against Antimicrobial Peptides Involves Extracellular Sensing Coupled with Membrane Remodeling Mediated by a Single Protein
    Ayesha Khan, B.Sc.; Milya Davlieva, Ph.D.; Diana Panesso, PhD; Sandra Rincon, M.Sc.; Truc Tran, PharmD; Xu Wang, B.Sc.; Kavindra Singh, Ph.D.; William Miller, MD; Yousif Shamoo, Ph.D.; Cesar Arias, MD, PhD, FIDSA
    337
    Unidirectional recombination of antibiotic resistance genes within nasopharyngeal pneumococcal biofilm consortia
    Santiago Lattar, PhD; Jennifer Brophy, BSc; Xueqing Wu, PhD; Fuminori Sakai, MD, PhD; Jorge Vidal, PhD
    338
    The LiaR-Regulon of Daptomycin-Resistant Enterococcus faecium
    Diana Panesso, PhD; Mauricio Latorre, PhD; Sandra Rincon, MSc; William Miller, MD; Lorena Diaz, PhD; Jinnethe Reyes, PhD; Rafael Rios, MSc; Javier Ardila, MSc; Lina Paola Carvajal, BSc; Cesar Arias, MD, PhD, FIDSA
    339
    Ceftazidime/avibactam Susceptibility Patterns in Carbapenem-Resistant Enterobacteriaceae in the US: Results from the Consortium on Resistance against Carbapenems in Klebsiella and Other Enterobacteriaceae (CRACKLE-2)
    David Van Duin, MD, PhD; Romney Humphries, PhD; Jesse T. Jacob, MD; Eric Cober, MD; Sandra S. Richter, MD; Yohei Doi, MD, PhD; Keith S. Kaye, MD, MPH; Sorabh Dhar, MD; Cesar Arias, MD, PhD, FIDSA; Angela Kim, MD; Julia Garcia-Diaz, MD, FIDSA; Jennifer H. Han, MD, MSCE; Michael Satlin, MD; Samit Desai, MD; Gregory Weston, MD, MS; Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA; Bettina Fries, MD, FIDSA; Robert Salata, MD; Darren Wong, MD; Glenn Wortmann, MD; Robert Kalayjian, MD; W. Charles Huskins, MD, MSc, FIDSA, FSHEA, FPIDS; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Brandon Eilertson, MD; Lauren Komarow, MS; Michelle Earley, MS; Scott R. Evans, PhD; Steve H. Marshall, MS; Susan D. Rudin, BS; T. Nicholas Domitrovic, MS; Andrea Hujer, BS; Kristine M. Hujer, BS; Robert A. Bonomo, MD
    340
    Minocycline enhances the antimicrobial capacity of unpolarized macrophages against Acinetobacter baumannii while inducing an anti-inflammatory profile
    Alberto Guerra, PhD; Warren Rose, PharmD, MPH; David R. Andes, M.D., FIDSA; Peiman Hematti, MD; Weiyuan John Kao, PhD
    Posters
  • Guerra IDWeek2017 FINAL.pdf (2.6 MB)
  • 343
    Emergence of Daptomycin (DAP) Resistance in Community-Associated MRSA USA300 Latin American Variant (USA300-LV)
    Jinnethe Reyes, PhD; Ernesto Martinez, MD; Lina Paola Carvajal, BSc; Aura Echeverri, MSc; Cristhian Hernández-Gómez, MSc; Lorena Diaz, PhD; Javier Ardila, MSc; Rafael Rios, MSc; David Aragon, MD; Diego Martinez, MD; Elsa De La Cadena, MSc; Carolina Ferro, BSc; Claudia Gonzalez, MD; Maria Virginia Villegas, MD, MSc, FIDSA; Cesar Arias, MD, PhD, FIDSA
    344
    Correcting for Antimicrobial Testing Methodology Reveals Temporary Decline in Daptomycin MIC Following Intervention 
    Clare Kinnear, PhD MIPH; Carol Young, MT(ASCP); Duane Newton, PhD; Twisha Patel, PharmD; Andrew Read, DPhil; Robert Woods, MD PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.